SJM
21
-3
SE
63
5
HSIC
57
4
GD
39
-2
MU
42
7
PSA
51
-2
BLK
63
-4
GIS
34
-3
UNH
46
-6
HCP
52
9
PH
66
2
ABBV
40
-2
EOG
36
2
TSN
32
-3
MOS
50
4
NDAQ
56
4
ADSK
67
2
AVB
57
2
CLX
65
-4
ESS
59
2
SJM
21
-3
SE
63
5
HSIC
57
4
GD
39
-2
MU
42
7
PSA
51
-2
BLK
63
-4
GIS
34
-3
UNH
46
-6
HCP
52
9
PH
66
2
ABBV
40
-2
EOG
36
2
TSN
32
-3
MOS
50
4
NDAQ
56
4
ADSK
67
2
AVB
57
2
CLX
65
-4
ESS
59
2
Financhill
Back

CI DoubleLine Total Rtn Bd US$ ETF C$ Vs. Aligos Therapeutics Industry Stock Comparison

Buy
65

CDLB.B.TO
CI DoubleLine Total Rtn Bd US$ ETF C$

Last Price:
17.34
Seasonality Move:
-1.66%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
33.28
Seasonality Move:
10.65%
Buy
65
CI DoubleLine Total Rtn Bd US$ ETF C$ (CDLB.B.TO) is a Buy

Is CI DoubleLine Total Rtn Bd US$ ETF C$ a Buy, Sell or Hold?

  • The current CI DoubleLine Total Rtn Bd US$ ETF C$ [CDLB.B.TO] share price is $17.34. The Score for CDLB.B.TO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • CDLB.B.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CDLB.B.TO Stock Price Chart

What is CI DoubleLine Total Rtn Bd US$ ETF C$'s stock price today?

  • The CI DoubleLine Total Rtn Bd US$ ETF C$ share price today is $17.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDLB.B.TO is experiencing slight buying pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

CDLB.B.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.26 Buy
Relative Strength Index (14 RSI): 100 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.34 - 17.3) Buy
Bollinger Bands (100): (16.12 - 16.76) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

CDLB.B.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.34 Sell
20-day SMA: 16.94 Buy
50-day SMA: 16.57 Buy
200-day SMA: 16.38 Buy
8-day EMA: 17.29 Buy
20-day EMA: 17.04 Buy
50-day EMA: 16.71 Buy
200-day EMA: 16.45 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

CI DoubleLine Total Rtn Bd US$ ETF C$ Earnings Growth & CDLB.B.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

CI DoubleLine Total Rtn Bd US$ ETF C$ Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):